Serum Institute-Sputnik V
Serum Institute gets preliminary approval to make Sputnik V vaccine
Pune/IBNS: Adar Poonawalla's Serum Institute of India (SII) has got preliminary permission from the country's drugs regulator to make the Russian COVID-19 vaccine Sputnik V, media reports said.
Poonawalla's company will test, analyse and then manufacture the vaccine at its Pune plant, NDTV quoting sources said.
The test licence granted to the Serum Institute will make it possible for the pharma company to develop and manufacture the product for testing, but not sell it.
"We have got preliminary approval for Sputnik V. But actual manufacturing will take several months. In the meantime, our focus remains Covishield and Covovax," SII spokesperson told NDTV.
The first dose of Sputnik V was administered in Hyderabad on May 14.
Sputnik V has been developed by Gamaleya Research Institute of Epidemiology and Microbiology in Russia.
It was approved by the Indian government for use in the country alongside two indigenous vaccines-Covaxin and Covishield.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
